Discovery of Pyrazolopyrazines as Selective, Potent, and Mutant-Active MET Inhibitors with Intracranial Efficacy. - Bumpers QA; Pipal RW; Benz-Weeden AM; Brewster JT 2nd; Cook A; Crooks AL; Cruz C; Dwulet NC; Gaudino JJ; Golec D; Harrison JA; Hartley DP; et al. (Journal of medicinal chemistry, 2024)